SENSEX
NIFTY
GOLD
USD/INR

Weather

image 20    C

Top News News

The Hindu

Top News / The Hindu

details

Why did the U.S. FDA decline to review the new mRNA influenza vaccine?

The debate here is not about the legitimacy of mRNA vaccines. It is about whether the right comparator was chosen in a clinical trial and whether that design is sufficient for regulatory review

13 Feb 2026 6:07 pm